31.19
price down icon0.45%   -0.14
after-market 시간 외 거래: 31.60 0.41 +1.31%
loading
전일 마감가:
$31.33
열려 있는:
$30.89
하루 거래량:
299.94K
Relative Volume:
0.25
시가총액:
$2.39B
수익:
$13.17M
순이익/손실:
$-199.06M
주가수익비율:
-11.38
EPS:
-2.74
순현금흐름:
$-156.53M
1주 성능:
-1.36%
1개월 성능:
-0.95%
6개월 성능:
-21.99%
1년 성능:
-28.76%
1일 변동 폭
Value
$30.84
$31.24
1주일 범위
Value
$30.84
$32.72
52주 변동 폭
Value
$26.74
$46.00

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
명칭
Xenon Pharmaceuticals Inc
Name
전화
(604) 484-3300
Name
주소
200 - 3650 GILMORE WAY, BURNABY
Name
직원
327
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
XENE's Discussions on Twitter

XENE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
XENE
Xenon Pharmaceuticals Inc
31.19 2.40B 13.17M -199.06M -156.53M -2.74
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-07 개시 Chardan Capital Markets Buy
2025-02-11 개시 Deutsche Bank Buy
2024-10-10 재개 Raymond James Outperform
2024-10-01 개시 H.C. Wainwright Buy
2024-01-04 개시 Citigroup Buy
2023-12-08 개시 Robert W. Baird Outperform
2023-10-24 재개 Cantor Fitzgerald Overweight
2023-04-25 개시 Cantor Fitzgerald Overweight
2022-12-14 개시 Goldman Buy
2022-12-12 개시 Cowen Outperform
2022-11-28 개시 Wells Fargo Overweight
2022-10-19 개시 Raymond James Outperform
2022-08-29 개시 BofA Securities Buy
2022-07-21 개시 JP Morgan Overweight
2021-10-28 개시 RBC Capital Mkts Outperform
2020-10-02 개시 SVB Leerink Outperform
2020-07-21 개시 Needham Buy
2020-06-01 재개 Jefferies Buy
2020-03-25 개시 Wedbush Outperform
2020-01-08 개시 William Blair Outperform
2019-09-20 개시 Guggenheim Buy
2018-08-08 재확인 Stifel Buy
2017-03-13 개시 Jefferies Buy
2016-10-21 개시 Stifel Buy
2016-09-26 개시 Guggenheim Buy
2016-04-14 재확인 Jefferies Buy
2015-10-30 재개 Jefferies Buy
2014-12-02 개시 Canaccord Genuity Buy
모두보기

Xenon Pharmaceuticals Inc 주식(XENE)의 최신 뉴스

pulisher
03:42 AM

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by Bank of New York Mellon Corp - Defense World

03:42 AM
pulisher
Jul 22, 2025

How Xenon Pharmaceuticals Inc. stock performs during market volatilityFree Access to Community - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Xenon Pharmaceuticals Inc. Stock Analysis and ForecastFree Bull & Bear Market Updates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Xenon Pharmaceuticals Inc. a good long term investmentFree Stock Selection - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Xenon Pharmaceuticals Inc. stock priceHigh-octane financial growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Xenon Pharmaceuticals Inc. stockRapid profit acceleration - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Mutual of America Capital Management LLC Buys New Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Should I buy Xenon Pharmaceuticals Inc. stock before earningsFree Smart Money Stock Analysis - Newser

Jul 20, 2025
pulisher
Jul 19, 2025

(XENE) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 16, 2025

Teacher Retirement System of Texas Reduces Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Xenon Pharmaceuticals Inc. stock attracts strong analyst attentionReliable High Profit Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Xenon Pharmaceuticals Inc. stock price move sharplyHigh Yield Opportunities - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely - Yahoo Finance

Jul 14, 2025
pulisher
Jul 10, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jul 10, 2025
pulisher
Jul 10, 2025

Traders Buy Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Jul 10, 2025
pulisher
Jul 08, 2025

How to Take Advantage of moves in (XENE) - news.stocktradersdaily.com

Jul 08, 2025
pulisher
Jul 07, 2025

CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com

Jul 07, 2025
pulisher
Jul 06, 2025

RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug - MSN

Jul 06, 2025
pulisher
Jul 04, 2025

Xenon Appoints CEO Ian Mortimer as Interim CFO - The Globe and Mail

Jul 04, 2025
pulisher
Jul 03, 2025

XENE CEO Named Interim CFO After Sherry Aulin Resigns | XENE SEC FilingForm 8-K - Stock Titan

Jul 03, 2025
pulisher
Jun 30, 2025

Xenon Pharmaceuticals Inc.(NasdaqGM:XENE) added to Russell Small Cap Comp Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Xenon Pharmaceuticals: Riding the Russell Wave to Institutional Inflows and Clinical Milestones? - AInvest

Jun 29, 2025
pulisher
Jun 28, 2025

Xenon Joins the Russell 3000® and Russell 2000® Indexes - The Manila Times

Jun 28, 2025
pulisher
Jun 27, 2025

Xenon Pharmaceuticals added to Russell 3000 and 2000 indexes - Investing.com India

Jun 27, 2025
pulisher
Jun 27, 2025

Xenon Pharmaceuticals Inc. Added to Russell 3000® and Russell 2000® Indexes in Annual Reconstitution - Quiver Quantitative

Jun 27, 2025
pulisher
Jun 26, 2025

Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees - TipRanks

Jun 26, 2025
pulisher
Jun 25, 2025

Is Xenon Pharmaceuticals, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

Xenon Announces Appointment of Darren Cline as Chief Commercial Officer - The Globe and Mail

Jun 24, 2025
pulisher
Jun 18, 2025

Long Term Trading Analysis for (XENE) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 15, 2025

Xenon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:XENE) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

RBC Capital Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $57 - 富途牛牛

Jun 14, 2025
pulisher
Jun 13, 2025

Xenon Pharmaceuticals price target raised to $57 from $55 at RBC Capital - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

RBC Raises Price Target on Xenon Pharmaceuticals to $57 From $55, Keeps Outperform, Speculative Risk - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Cantor Fitzgerald Estimates XENE FY2026 Earnings - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Traders Purchase High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for XENE FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Xenon Pharmaceuticals at Goldman Sachs Conference: Strategic Clinical Advances By Investing.com - Investing.com Canada

Jun 10, 2025

Xenon Pharmaceuticals Inc (XENE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
자본화:     |  볼륨(24시간):